-
drive our multiomics, high-throughput sequencing projects and help develop any projects based on the most advanced technologies. Your qualifications should include: Ph.D. in Biochemistry, Bioinformatics
-
of Hope. This role offers an exciting opportunity to investigate immune checkpoint signaling within the tumor microenvironment and contribute to the development of novel anticancer therapies
-
are working on this may be the perfect opportunity: 1. Development of cell-free DNA (mutation and methylation), RNA, and exosomal-based liquid assays for early cancer detection, prognosis, and predictive
-
) development of small molecule drugs and PROTAC-drug conjugates. The Li group conducts the most forefront science and is highly productive with publications in high-impact journals in the past five years, Nature
-
. Develop new techniques/protocols and help other lab projects.
-
of adipose tissue and its link to age-related metabolic disorders and cancer. Ultimately, we aim to mitigate the pathogenesis and develop treatments for chronic metabolic diseases. We have established unique
-
Medicine, Beckman Research Institute. The Postdoctoral Fellow will be working in a highly collaborative group on a variety of multidisciplinary research projects with a common theme of developing and
-
failure from a developmental perspective. We are interested in the dynamics of beta-cell heterogeneity, islet organization and cell-cell interaction in fetal and neonatal development. The Dhawan lab
-
have been focused on exploring the molecular mechanisms of leukemogenesis and evolution, discovery of novel therapeutic targets, and development of novel therapeutic strategies, including novel
-
(EVs), for groundbreaking minimally invasive diagnostics. Uncover disease-specific molecules within EVs using cell biology and super-resolution microscopy. Contribute to developing a revolutionary